The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,671.50
Bid: 1,671.00
Ask: 1,672.00
Change: 1.50 (0.09%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,671.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Dividends Calendar - Week Ahead

Wed, 05th Nov 2014 16:00

Thursday, November 6 
JZ Capital PartnersEx-dividend date 2014
Morgan Advanced MaterialsEx-dividend date 2014
ReddeEx-dividend date 2014
Aberdeen Asian Smaller CompaniesEx-dividend date 2014
Bloomsbury PublishingEx-dividend date 2014
JPMorgan Claverhouse Investment TrustEx-dividend date 2014
Plexus HoldingsEx-dividend date 2014
BrammerEx-dividend date 2014
BlackRock Smaller Companies TrustEx-dividend date 2014
Ashmore GroupEx-dividend date 2014
AbcamEx-dividend date 2014
BarclaysEx-dividend date 2014
BPEx-dividend date 2014
BunzlEx-dividend date 2014
Dechra PharmaceuticalsEx-dividend date 2014
Dunedin Income Growth Investment TrustEx-dividend date 2014
Henderson Far East IncomeEx-dividend date 2014
HuntingEx-dividend date 2014
James HalsteadEx-dividend date 2014
JPMorgan Overseas Investment TrustEx-dividend date 2014
LairdEx-dividend date 2014
PaceEx-dividend date 2014
SThreeEx-dividend date 2014
Stobart GroupEx-dividend date 2014
UnileverEx-dividend date 2014
British & American Investment TrustPayment Date 2014 Dividend
Photo-Me InternationalPayment Date 2014 Dividend
SynthomerPayment Date 2014 Dividend
GlaxoSmithKlineEx-dividend date 2014
JPMorgan Smaller Companies ITEx-dividend date 2014
UK Commercial Property TrustEx-dividend date 2014
RegenersisEx-dividend date 2014
Ecofin Water & Power OpportunitiesEx-dividend date 2014
Starwood European Real Estate FinanceEx-dividend date 2014
Aberdeen Asian Smaller Companies ITSpecial Dividend Payment Date
Friday, November 7 
Spirax-Sarco EngineeringPayment Date 2014 Dividend
Clinigen GroupPayment Date 2014 Dividend
F&C Private Equity TrustPayment Date 2014 Dividend
Primary Health PropertiesPayment Date 2014 Dividend
Weir GroupPayment Date 2014 Dividend
BodycotePayment Date 2014 Dividend
SIGPayment Date 2014 Dividend
British Land CoPayment Date 2014 Dividend
CobhamPayment Date 2014 Dividend
Johnson Service GroupPayment Date 2014 Dividend
RightmovePayment Date 2014 Dividend
Unite GroupPayment Date 2014 Dividend
Schroder Japan Growth FundPayment Date 2014 Dividend
jupiter Dividend & Growth TrustPayment Date 2014 Dividend
JPMorgan Senior Secured Loan FundPayment Date 2014 Dividend
Monday, November 10 
Wilmington GroupPayment Date 2014 Dividend
WM Morrison SupermarketsPayment Date 2014 Dividend
WPPPayment Date 2014 Dividend
Finsbury Growth & Income TrustPayment Date 2014 Dividend
Tuesday, November 11 
Smith & NephewPayment Date 2014 Dividend
Travis PerkinsPayment Date 2014 Dividend
Merrchants TrustPayment Date 2014 Dividend
Wednesday, November 12 
SpectrisPayment Date 2014 Dividend
JPMorgan Mid Cap Investment TrustPayment Date 2014 Dividend
CentricaPayment Date 2014 Dividend
  
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.